These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 15319461)
1. Effects of dietary cholesterol on plasma lipoproteins in Smith-Lemli-Opitz syndrome. Merkens LS; Connor WE; Linck LM; Lin DS; Flavell DP; Steiner RD Pediatr Res; 2004 Nov; 56(5):726-32. PubMed ID: 15319461 [TBL] [Abstract][Full Text] [Related]
2. Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome. Witsch-Baumgartner M; Gruber M; Kraft HG; Rossi M; Clayton P; Giros M; Haas D; Kelley RI; Krajewska-Walasek M; Utermann G J Med Genet; 2004 Aug; 41(8):577-84. PubMed ID: 15286151 [TBL] [Abstract][Full Text] [Related]
3. Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome. Linck LM; Lin DS; Flavell D; Connor WE; Steiner RD Am J Med Genet; 2000 Aug; 93(5):360-5. PubMed ID: 10951458 [TBL] [Abstract][Full Text] [Related]
4. Intestinal absorption of cholesterol by patients with Smith-Lemli-Opitz syndrome. Lin DS; Steiner RD; Flavell DP; Connor WE Pediatr Res; 2005 Jun; 57(6):765-70. PubMed ID: 15774833 [TBL] [Abstract][Full Text] [Related]
5. Sterol concentrations in cultured Smith-Lemli-Opitz syndrome skin fibroblasts: diagnosis of a biochemically atypical case of the syndrome. Honda A; Tint GS; Salen G; Kelley RI; Honda M; Batta AK; Chen TS; Shefer S Am J Med Genet; 1997 Jan; 68(3):282-7. PubMed ID: 9024560 [TBL] [Abstract][Full Text] [Related]
6. [Biochemical diagnosis of Smith-Lemli-Opitz syndrome in a patient with congenital adrenal hyperplasia]. GarcíaFuentes E; icioso Recio MV ; del Castillo Acedo Del Olmo E ; atas Jurado MM ; Arana Agüera M ; López López J An Esp Pediatr; 2000 Nov; 53(5):482-7. PubMed ID: 11141372 [TBL] [Abstract][Full Text] [Related]
7. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients. Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653 [TBL] [Abstract][Full Text] [Related]
9. Smith-Lemli-Opitz syndrome: the first malformation syndrome associated with defective cholesterol synthesis. Battaile KP; Steiner RD Mol Genet Metab; 2000; 71(1-2):154-62. PubMed ID: 11001806 [TBL] [Abstract][Full Text] [Related]
10. [Smith-Lemli-Opitz syndrome; a special defect in cholesterol metabolism]. Aalfs CM; Hennekam RC; Wanders RJ; Jira PE; Pilon JW; Wijburg FA Ned Tijdschr Geneeskd; 1996 Jul; 140(28):1463-6. PubMed ID: 8766772 [TBL] [Abstract][Full Text] [Related]
11. [Historical aspects of the Smith-Lemli-Opitz syndrome]. Bzdúch V; Behúlová D; Skodová J; Skokňová M; Kozák L Cas Lek Cesk; 2014; 153(1):36-9. PubMed ID: 24506692 [TBL] [Abstract][Full Text] [Related]
12. Aripiprazole and trazodone cause elevations of 7-dehydrocholesterol in the absence of Smith-Lemli-Opitz Syndrome. Hall P; Michels V; Gavrilov D; Matern D; Oglesbee D; Raymond K; Rinaldo P; Tortorelli S Mol Genet Metab; 2013; 110(1-2):176-8. PubMed ID: 23628460 [TBL] [Abstract][Full Text] [Related]